The Technical Field "用量" had 1,178 patent application filings in the most recent period (2022-01-01 to 2022-08-31). This is a significantly decreased of -576 filings (-32.8%) over 1,754 they had in the same period of the previous year (2021-01-01 to 2021-08-31). This report also includes technical terms related to " 使用量 ", " 投与量 ", " 投薬量 ", " 薬用量 " in the search set.
The highest number of filings in 2017 with 3,094 cases, and their lowest number in 2022 with 1,363 cases.
The mean of the number of filings over the last 5 years (2018 to 2023, 12,386 cases in total) is 2,064, and the median is 2,562. The coefficient of variation (standard deviation/mean) is 0.5, and there have been big fluctuations in the number of filings from year to year.
Index | Value |
---|---|
Average | 2,064 patents |
Std Dev | 1,012 |
COV | 0.5 |
The number of filings has been decreasing for the last 3 years (2020 to 2023).
Year | Cases | YOY |
---|---|---|
2022 year | 1,363 cases | -47.2 % |
2021 year | 2,579 cases | +1.30 % |
2020 year | 2,546 cases | -8.65 % |
This report provides the latest patent analysis information (the IP landscape, including a patent map) on the patent search results of the JP patent database for 用量 for the period of the last 10 years (2014-01-01 to 2024-04-30). You can compare the information in this report with the trends in your competitors’ patent filings and technologies, and use it to search for important patents.
This service provides, free of charge, a patent analysis report based on the latest patent data (Japanese, U.S., European, and PCT application publications) for use in patent searches, patent analysis, and IP landscaping. The service is offered by "Patent Integration" a firm specializing in patent search/patent analysis.
This report includes basic information to help you understand the IP strategy and management of 用量, such as changes in the number of patents/patent applications they have filed, comparisons of the numbers of patents/patent applications filed by their peers and competitors, their top coapplicants (joint research partners, alliance partners), and their most important patents. It can be used in various intellectual property business operations such as IP landscaping, patent search/patent analysis, preparation of intellectual property business evaluation reports, selection of M&A candidates, and selection of alliance partners.
He is a patent attorney at a patent office. He specializes in invention counseling, patent filing, and intellectual property strategies for start-up companies and new businesses in the fields of software, information technology and artificial intelligence. He runs a patent course for beginners on Udemy, an online course provider.
After studying physics at the University of Tokyo as a doctoral student, he was engaged in intellectual property analysis and technology trend research as an in-house patent attorney at a precision equipment manufacturer and at Toyota Central R&D Labs. Inc..
The concept of the "IP landscape" (IPL) has been attracting attention recently.
An IP landscape is not limited to patent information, but also integrates and analyzes business information (e.g., non-patent information such as papers, news releases, stock information, and market information). Intellectual-property-based business management is realized through the analysis of intellectual property information applied to the formulation of management strategies and business strategies. This is a comprehensive approach that includes but not limited to planning of open and closed strategies, selecting M&A candidates, searching for alliance partners, and formulating intellectual property strategies, through the exploitation of intellectual property information.
IP landscaping usually includes patent search and patent analysis. In patent search and patent analysis, it is important to grasp the market position of each company and the overall technological trends and development trends for each technology. More specifically, it is important to understand what intellectual property your own company and other companies hold, what the strengths and weaknesses of other companies are, and how other companies are trying to exploit their intellectual property. In other words, it is important to understand both the business strategy and the intellectual property strategy of each company.
After reading this search report, you may be interested in more detailed patent searches and patent analysis. We offer a service called Patent Integration, which is an integrated patent search and patent analysis service. With reasonable pricing and a simple user interface such that even beginners can quickly search for and analyze patent information by company or technology from a web browser, please consider using it for detailed patent searches, patent analysis, and IP landscaping.
Patent Integration has a patent-landscaping function that can visually represent a set of tens of thousands of patents/patent applications. This allows you to convincingly show the technical positions of your company and its competitors to your management and business strategists in order to formulate management strategies and business strategies.
The changes in the number of patent filings of 用量 over the last 20 years (JP) are shown below.
The change in the number of patents/patent applications is the most basic index in patent analysis. By examining the change in the number of patents/patent applications, you can see the status of technological development and R&D focus for each company or technology. It should be noted that since there is a one and a half year lag between the filing and the laying open of patent applications, it is not possible to analyze the situation more recently than one and half years prior to the present.
In this report, you can only see the change in the number of patents/patent applications by company or technology, whereas Patent Integration allows you to quickly compare the number of patent applications with your competitors in each technical field by cross-referencing with other keywords and patent classifications.
This patent analysis report was created for a patent search set of 24,448 cases retrieved by applying the following search formula and analysis period to the following patent database. Patent information such as a patent analysis result, a patent map, and a patent landscape can be freely used for patent searches, analysis, and work on intellectual property strategies, including IP landscaping.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 用量 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Comparing the number of applications of each company, キヤノン株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 18 cases, followed by ノバルティスアーゲー with 16 cases.
Name | Cases |
---|---|
キヤノン株式会社 | 18 cases |
ノバルティスアーゲー | 16 cases |
三菱電機株式会社 | 12 cases |
株式会社日立製作所 | 10 cases |
セイコーエプソン株式会社 | 10 cases |
富士通株式会社 | 7 cases |
住友化学株式会社 | 4 cases |
株式会社東芝 | 2 cases |
パナソニックホールディングス株式会社 | 1 cases |
株式会社リコー | 1 cases |
Comparing the number of applications of each company, ノバルティスアーゲー has the highest number of joint applications in the last for the target period (2014 to 2024) with 392 cases, followed by キヤノン株式会社 with 289 cases.
Name | Cases |
---|---|
ノバルティスアーゲー | 392 cases |
キヤノン株式会社 | 289 cases |
サノフィ-アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | 180 cases |
三菱電機株式会社 | 126 cases |
富士通株式会社 | 121 cases |
株式会社リコー | 110 cases |
株式会社日立製作所 | 103 cases |
セイコーエプソン株式会社 | 82 cases |
株式会社東芝 | 67 cases |
住友化学株式会社 | 38 cases |
パナソニックホールディングス株式会社 | 11 cases |
Below is a patent map showing changes in the number of applications for JP patents of 11 companies in the same industry over the past 20 years.
The number of patents and changes in the number of patents of other companies (competitors) in the same industry as 用量 are shown below.
Comparison of changes in the number of patents with peers and competitors is an important analytical index for understanding the intellectual property strategies of each company. By checking the transition of the number of patents for each company / competitor, you can check the status of focus on technology development and R&D for each company / technology.
It should be noted that patents have a time lag of one and a half years from filing to publication, so it is not possible to analyze the situation more recent than one and a half years.
If you want to find out more information, " Patent Integration , You can compare the number of patent applications with competitors in each technical field in a short time by multiplying with other keywords and patent classifications.Please use it for more detailed patent information analysis such as selection of M&A candidate destinations and alliance destinations.
Among the top coapplicants, キヤノン株式会社 has the highest number of joint applications in the last in the last 3 years (2022 to 2024) with 18 cases, followed by ノバルティスアーゲー with 16 cases.
Name | Cases |
---|---|
キヤノン株式会社 | 18 cases |
ノバルティスアーゲー | 16 cases |
株式会社日立製作所 | 10 cases |
セイコーエプソン株式会社 | 10 cases |
住友化学株式会社 | 4 cases |
株式会社東芝 | 2 cases |
パナソニックホールディングス株式会社 | 1 cases |
Among the top coapplicants, ノバルティスアーゲー has the highest number of joint applications in the last for the target period (2014 to 2024) with 392 cases, followed by キヤノン株式会社 with 289 cases.
Name | Cases |
---|---|
ノバルティスアーゲー | 392 cases |
キヤノン株式会社 | 289 cases |
株式会社日立製作所 | 103 cases |
セイコーエプソン株式会社 | 82 cases |
株式会社東芝 | 67 cases |
住友化学株式会社 | 38 cases |
パナソニックホールディングス株式会社 | 11 cases |
Below is a ranking of the number of JP patent applications by 用量’s top 7 coapplicants over the last 20 years.
Below is a patent map showing the changes in the numbers of JP patent filings by 用量’s top 7 coapplicants over the last 20 years.
用量 filed 289 joint applications with キヤノン株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 139 cases in total) is 23.2, and the median is 18.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 46 cases, and their lowest number in 2022 with 16 cases.
Index | Value |
---|---|
Average | 23.2 patents |
Std Dev | 14.5 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 16 cases | -15.79 % |
2021 year | 19 cases | +5.56 % |
2020 year | 18 cases | -56.1 % |
用量 filed 103 joint applications with 株式会社日立製作所 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 41 cases in total) is 6.8, and the median is 8.0. The coefficient of variation (standard deviation/mean) is 0.3, and there have been big fluctuations in the number of filings from year to year.
The number of filings has been decreasing for the last 3 years (2020 to 2023). The highest number of filings in 2015 with 22 cases, and their lowest number in 2018 with 6 cases.
Index | Value |
---|---|
Average | 6.8 patents |
Std Dev | 2.3 |
COV | 0.3 |
Year | Cases | YOY |
---|---|---|
2022 year | 8 cases | 0 |
2021 year | 8 cases | -11.11 % |
2020 year | 9 cases | +12.50 % |
用量 filed 11 joint applications with パナソニックホールディングス株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 5 cases in total) is 0.8, and the median is 0.5. The coefficient of variation (standard deviation/mean) is 1.1, and there have been very big fluctuations in the number of filings from year to year.
The highest number of filings in 2017 with 4 cases, and their lowest number in 2021 with 0 cases.
Index | Value |
---|---|
Average | 0.8 patents |
Std Dev | 0.9 |
COV | 1.1 |
Year | Cases | YOY |
---|---|---|
2022 year | 1 cases | - |
2021 year | 0 cases | - |
2020 year | 0 cases | -100 % |
用量 filed 392 joint applications with ノバルティスアーゲー for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 184 cases in total) is 30.7, and the median is 33.5. The coefficient of variation (standard deviation/mean) is 0.6, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2014 with 62 cases, and their lowest number in 2022 with 15 cases.
Index | Value |
---|---|
Average | 30.7 patents |
Std Dev | 19.1 |
COV | 0.6 |
Year | Cases | YOY |
---|---|---|
2022 year | 15 cases | -44.4 % |
2021 year | 27 cases | -32.5 % |
2020 year | 40 cases | -2.44 % |
用量 filed 38 joint applications with 住友化学株式会社 for the analysis period (2014 to 2024).
The mean of the number of filings over the last 5 years (2018 to 2023, 15 cases in total) is 2.5, and the median is 3.0. The coefficient of variation (standard deviation/mean) is 0.8, and there have been relatively large fluctuations in the number of filings from year to year.
The highest number of filings in 2016 with 7 cases, and their lowest number in 2020 with 0 cases.
Index | Value |
---|---|
Average | 2.5 patents |
Std Dev | 2.0 |
COV | 0.8 |
Year | Cases | YOY |
---|---|---|
2022 year | 4 cases | +100 % |
2021 year | 2 cases | - |
2020 year | 0 cases | -100 % |
The following shows JP patents held by 用量 that have had an invalidation trial against them demanded or an opposition filed against them by a third party, and 用量’s JP patents/patent applications of high importance cited by Examiners in patent examination processes.
By noting the most important patents, you can obtain knowledge of the competitive business environment in which 用量 is placed (e.g., whether it is a fiercely competitive environment or an oligopolistic market and the like). In general, it can be understood that a company with a large number of demands for invalidation trials is developing their business in a business environment where IP disputes are common.
If you want to search for more detailed information, you can use Patent Integration to retrieve and download by company cited patents/patent applications or patents undergoing invalidation trials. You can quickly extract important patents from a patent set that includes multiple competitors by cross-referencing with other keywords and patent classifications. Please consider using it for searches for important patents/patent applications.
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 15 patents Invalidation Trial from third parties. The average number of Invalidation Trial is 1.3 times. The most recently Invalidation Trial patent is 特許6995822 "DPP IVインヒビターの使用" (Invalidation Trial day 2024-03-19) , next is 特許6143809 "DPPIVインヒビターの使用" (Invalidation Trial day 2024-02-29) .
- | No. | Title | Invalidation Trial days |
---|---|---|---|
1 | 特許6995822 | DPP IVインヒビターの使用 | 2024-03-19 |
2 | 特許6143809 | DPPIVインヒビターの使用 | 2024-02-29 |
3 | 特許6262023 | 経口又は非経口抗糖尿病薬による治療にもかかわらず不十分な血糖調節の患者の糖尿病の治療 | 2024-01-31 |
4 | 特許6189374 | 糖尿病療法 | 2024-01-31 |
5 | 特許6740497 | 癌を治療するための方法及び組成物 | 2023-11-25 |
6 | 特許7219217 | 貯蔵及び送達システム | 2023-10-26 |
7 | 特許6290627 | メトホルミン治療に不適切な患者における糖尿病の治療 | 2023-09-07 |
8 | 特許6662970 | DPP IVインヒビターの使用 | 2023-09-04 |
9 | 特許7185426 | S1P受容体モジュレーターの投与計画 | 2023-07-10 |
10 | 特許5927146 | DPP IVインヒビターの使用 | 2023-07-10 |
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 11 patents/patent applications were invalidation trial more than once in the examination process of other patent applications. The mean of the number of invalidation trial is 1.1. The most invalidation trial patent is 特許6143809 "DPPIVインヒビターの使用" (2 times) , and the next most invalidation trial patent is 特許5910698 "リセドロネート組成物およびその使用方法" (1 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6143809 | DPPIVインヒビターの使用 | 2 times |
2 | 特許5910698 | リセドロネート組成物およびその使用方法 | 1 times |
3 | 特許6662970 | DPP IVインヒビターの使用 | 1 times |
4 | 特許6466538 | 治療薬のCNS送達 | 1 times |
5 | 特許6283440 | 逆流性食道炎の再発抑制剤 | 1 times |
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 48 patents Opposition from third parties. The average number of Opposition is 1.0 times. The most recently Opposition patent is 特許7339222 "銑鉄製造方法" (Opposition day 2024-02-28) , next is 特許7354178 "凍結乾燥された飲料固化物" (Opposition day 2024-02-13) .
- | No. | Title | Opposition days |
---|---|---|---|
1 | 特許7339222 | 銑鉄製造方法 | 2024-02-28 |
2 | 特許7354178 | 凍結乾燥された飲料固化物 | 2024-02-13 |
3 | 特許7344242 | 凍結乾燥された緑茶飲料固化物 | 2024-02-13 |
4 | 特許7337312 | X線発生装置、X線撮像装置、および、X線発生装置の調整方法 | 2024-02-09 |
5 | 特許7317275 | 植物成長促進組成物 | 2024-01-31 |
6 | 特許7293549 | 高ヘイズアンチグレアフィルムおよび高ヘイズアンチグレア反射防止フィルム | 2023-12-20 |
7 | 特許7293550 | 高ヘイズアンチグレアフィルムおよび高ヘイズアンチグレア反射防止フィルム | 2023-12-20 |
8 | 特許7275044 | 慢性炎症性脱髄性多発神経炎の治療における使用のための免疫グロブリン製品 | 2023-11-17 |
9 | 特許7320206 | 固定胴型製茶機の熱風発生器 | 2023-10-19 |
10 | 特許7254138 | 射出成形に用いるポリエステル樹脂組成物の製造方法 | 2023-10-06 |
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 140 patents Protest from third parties. The average number of Protest is 1.5 times. The most recently Protest patent is 特開2023-050712 "水硬性硬化体の製造方法、水硬性硬化体" (Protest day 2024-04-23) , next is 特開2021-188037 "水性発泡耐火塗料組成物" (Protest day 2024-04-11) .
- | No. | Title | Protest days |
---|---|---|---|
1 | 特開2023-050712 | 水硬性硬化体の製造方法、水硬性硬化体 | 2024-04-23 |
2 | 特開2021-188037 | 水性発泡耐火塗料組成物 | 2024-04-11 |
3 | 特開2020-158156 | 包装材料及び包装製品 | 2024-04-02 |
4 | 特開2023-067994 | 包装材料及び包装製品 | 2024-04-02 |
5 | 特開2023-165777 | 包装材料及び包装製品 | 2024-04-02 |
6 | 特開2022-144583 | 混合セメント組成物 | 2024-03-28 |
7 | 特開2022-160165 | 包装用紙 | 2024-03-14 |
8 | 特開2021-138434 | 包装用紙 | 2024-02-28 |
9 | 特表2023-525856 | ATI消化のための方法及び組成物 | 2024-02-28 |
10 | 特開2022-115299 | 電解水生成装置 | 2024-02-22 |
11 | 特開2023-166957 | 化合物及びフマル酸の結晶形態、医薬組成物及びコロナウイルス誘発性疾患の治療方法 | 2024-02-20 |
12 | 特開2023-096145 | 包装用紙 | 2024-02-20 |
13 | 特開2023-108019 | 発酵アルコール飲料の製造方法並びにビールテイスト飲料及びワインテイスト飲料 | 2024-02-16 |
14 | 特開2022-035370 | トマトソースの製造方法 | 2024-02-14 |
15 | 特開2022-026979 | 腎機能低下ネコに対する腎機能保護剤およびそれを含むネコ用飼料及びネコ用医薬品 | 2024-01-29 |
16 | 特開2021-075498 | 非水系組成物および毛髪処理方法 | 2024-01-24 |
17 | 特開2022-141317 | 豆腐用凝固剤 | 2024-01-22 |
18 | 特開2021-195471 | 油脂中の3−MCPD含有量を低減させる方法 | 2024-01-12 |
19 | 特開2023-161047 | 育毛促進用組成物 | 2023-12-20 |
20 | 特開2023-044506 | 製紙用添加剤、製紙用添加剤の製造方法及び紙 | 2023-12-12 |
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 270 patents/patent applications were protest more than once in the examination process of other patent applications. The mean of the number of protest is 1.5. The most protest patent is 特許7085104 "薬品払出装置" (7 times) , and the next most protest patent is 特許7344242 "凍結乾燥された緑茶飲料固化物" (6 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許7085104 | 薬品払出装置 | 7 times |
2 | 特許7344242 | 凍結乾燥された緑茶飲料固化物 | 6 times |
3 | 特許7109153 | ウレタン(メタ)アクリレート樹脂及び積層フィルム | 5 times |
4 | 特開2017-061467 | 血管新生眼疾患を処置するためのVEGFアンタゴニストの使用 | 5 times |
5 | 特許6745579 | 炒め調理用の油脂組成物 | 5 times |
In the last 3 years (2021-05-01 ~ 2024-04-30), there were 471 patents Inspection from third parties. The average number of Inspection is 1.7 times. The most recently Inspection patent is 特許5795342 "2−[4−(3−及び2−フルオロベンジルオキシ)ベンジルアミノ]プロパンアミドの製造方法" (Inspection day 2024-04-19) , next is 特表2023-519762 "ジスフェリン二重ベクターを用いた遺伝子治療" (Inspection day 2024-04-17) .
- | No. | Title | Inspection days |
---|---|---|---|
1 | 特許5795342 | 2−[4−(3−及び2−フルオロベンジルオキシ)ベンジルアミノ]プロパンアミドの製造方法 | 2024-04-19 |
2 | 特表2023-519762 | ジスフェリン二重ベクターを用いた遺伝子治療 | 2024-04-17 |
3 | 特許7486437 | 免疫性血小板減少症を治療する組成物及び方法 | 2024-04-17 |
4 | 特表2023-526327 | 薬物の有効性を高めるための組成物及び方法 | 2024-04-16 |
5 | 特開2020-158156 | 包装材料及び包装製品 | 2024-04-12 |
6 | 特開2023-018038 | シヌクレイン病の治療のための投与レジメン | 2024-04-12 |
7 | 特表2021-525362 | 多発性骨髄腫を治療すること及び4−(4−(4−(((2−(2,6−ジオキソピペリジン−3−イル)−1−オキソイソインドリン−4−イル)オキシ)メチル)ベンジル)ピペラジン−1−イル)−3−フルオロベンゾニトリルのバイオマーカーの使用 | 2024-04-12 |
8 | 特開2022-058771 | 放出が改良された1-[(3-ヒドロキシ-アダマント-1-イルアミノ)-アセチル]-ピロリジン-2(S)-カルボニトリル製剤 | 2024-04-12 |
9 | 特開2023-067994 | 包装材料及び包装製品 | 2024-04-12 |
10 | 特開2023-108019 | 発酵アルコール飲料の製造方法並びにビールテイスト飲料及びワインテイスト飲料 | 2024-04-12 |
11 | 特開2023-165777 | 包装材料及び包装製品 | 2024-04-12 |
12 | 特表2021-524495 | 酸化的ストレスおよびミトコンドリアストレスから,細胞を保護する組成物 | 2024-04-12 |
13 | 特開2020-045332 | 慢性便秘症を治療するための医薬組成物 | 2024-04-11 |
14 | 特許6803229 | ベンラリツマブによる喘息症状の改善方法 | 2024-04-04 |
15 | 特開2022-065089 | ジフテリア毒素-インターロイキン-3コンジュゲートに基づく方法及び組成物 | 2024-04-01 |
16 | 特開2023-166957 | 化合物及びフマル酸の結晶形態、医薬組成物及びコロナウイルス誘発性疾患の治療方法 | 2024-03-28 |
17 | 特開2019-011372 | インターロイキン−6関連疾患の治療方法 | 2024-03-26 |
18 | 特許7467479 | 多発性骨髄腫の治療における抗増殖化合物及び第2の活性薬剤とそれらの併用方法 | 2024-03-22 |
19 | 特表2020-536960 | シロシビン、異なる多形形態、中間体、調合物の調製及びそれらの使用 | 2024-03-19 |
20 | 特表2021-516049 | 組換えT細胞受容体遺伝子を用いて細胞ベースの治療薬を製造するための技法 | 2024-03-19 |
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 783 patents/patent applications were inspection more than once in the examination process of other patent applications. The mean of the number of inspection is 1.6. The most inspection patent is 特開2017-149726 "B細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療" (46 times) , and the next most inspection patent is 特許6901451 "前立腺特異的膜抗原(PSMA)の標識インヒビター、前立腺癌の治療のための画像化剤および薬剤としてのその使用" (30 times) .
- | No. | Title | |
---|---|---|---|
1 | 特開2017-149726 | B細胞表面マーカーに結合するアンタゴニストを用いた自己免疫疾患の治療 | 46 times |
2 | 特許6901451 | 前立腺特異的膜抗原(PSMA)の標識インヒビター、前立腺癌の治療のための画像化剤および薬剤としてのその使用 | 30 times |
3 | 特許6142892 | 経口投与用医薬組成物 | 30 times |
4 | 特許6283440 | 逆流性食道炎の再発抑制剤 | 12 times |
5 | 特開2020-158156 | 包装材料及び包装製品 | 12 times |
Of the patent applications filed in the last 10 years (2014-05-01 to 2024-04-30), 3,966 patents/patent applications were cited more than once in the examination process of other patent applications. The mean of the number of cited is 2.4. The most cited patent is 特許6522128 "リソースサイジングの自動管理システム、方法及び非一時的コンピュータ可読記憶媒体" (71 times) , and the next most cited patent is 特開2018-055259 "情報処理装置、情報処理方法及びプログラム" (64 times) .
- | No. | Title | |
---|---|---|---|
1 | 特許6522128 | リソースサイジングの自動管理システム、方法及び非一時的コンピュータ可読記憶媒体 | 71 times |
2 | 特開2018-055259 | 情報処理装置、情報処理方法及びプログラム | 64 times |
3 | 特開2016-013151 | サーバシステム、ゲーム装置およびプログラム | 62 times |
4 | 特許6285078 | 圧力分散型拡大ヘッド付きアンカーロッドの施工方法及び構造 | 52 times |
5 | 特許6284542 | 正極活物質の製造方法、及びこれによって製造されたリチウム二次電池用正極活物質 | 34 times |
"Patent Integration Report" is a web service provided by "Patent Integration Co., Ltd." operated by patent attorneys who are experts in intellectual property rights. Based on the latest patent data, this is one of the largest patent report services in Japan that provides information on technology trends in various companies and technology fields.
The purpose of this web service is to make intellectual property information familiar to many people, regardless of whether they have an interest in intellectual property rights, and to make use of it.
We actively provide various types of patent information that can be used in various media articles such as newspapers, magazines, and web media. Please feel free to contact us from "Inquiry form for details on the content of patent information that can be provided, conditions for provision, etc. Please contact us.
All rights related to the data, documents and charts belong to "an integrated patent search/analysis service provider, Patent Integration". Please specify the source “Patent Integration Report, URL: https://patent-i.com/report/en/" when inserting them into in-house materials, external report materials, etc., regardless of whether they are paid or free of charge.
Patent data is obtained by aggregating and analyzing the latest patent data issued by the Patent Offices of respective countries and jurisdictions and by WIPO. Although we take great care in publishing and analyzing the results, we do not guarantee the correctness of the data. We appreciate your understanding.
If you have any concerns about this service, please feel free to contact us.
All rights to the data, documents, figures and tables are reserved by e-Patent. When publishing internal documents, external reports, etc. (whether paid or free of charge), please use the following URL: https://e-patent.co.jp/.
e-Patent will not be liable for any damages or losses arising from the use of the global patent application status, ranking information, or population search formula in the "SDGs Global Company Ranking from a Patent Perspective". Items with ● in front of the target are not supported at this time (judged to be difficult to approach from the patent information analysis).
There is no problem to cite patent application status and ranking information, but please clearly indicate "Source: e-Patent Co.
Credit notation
・MeCab user dictionary for science technology term © National Bioscience Database Center licensed under CC Attribution-Share Alike 4.0 International